National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
from NDTV News - Topstories https://ift.tt/Fep8WDX
from NDTV News - Topstories https://ift.tt/Fep8WDX
Comments
Post a Comment